Showing 1 - 20 results of 79,197 for search '(((( 50 ((ms decrease) OR (_ decrease)) ) OR ( 01 1 decrease ))) OR ( _ wt decrease ))*', query time: 1.19s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

    Published 2021
    “…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”
  7. 7
  8. 8
  9. 9

    Decreased E/I synapse ratio and loss of cortico-LA synaptic plasticity in the absence of coronin 1. by Rajesh Jayachandran (542641)

    Published 2014
    “…Forskolin enhances synaptic transmission and decreases PPR at cortico-LA synapses in WT (<i>n</i> = 12, <i>p</i><0.05 versus pre-forskolin baseline), but not in Cor 1 −/− (<i>n</i> = 7, <i>p</i>>0.05 versus pre-forskolin baseline, Student's <i>t</i> test) mice. …”
  10. 10
  11. 11

    DART-ID decreases missing datapoints across runs. by Albert Tian Chen (6900215)

    Published 2019
    “…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”
  12. 12
  13. 13
  14. 14

    <i>roh</i> mutation results in Rh1 decrease. by Yu Huang (15093)

    Published 2015
    “…Scale bar, 50 μm. (B) Western blotting showing decreased Rh1 levels in the <i>roh</i><sup><i>EY04039</i></sup> mutant (<i>ey-flp Rh1</i>::<i>GFP; FRT42D roh</i><sup><i>EY04039</i></sup><i>/ FRT42D GMR-hid CL</i>); the INAD and TRP levels are not affected compared to the wild-type. …”
  15. 15
  16. 16
  17. 17

    <i>Kdm6a</i> conditional KO mice have decreased repopulating potential in serial competitive transplantation assays. by Ling Tian (107492)

    Published 2021
    “…Whole BM cells were harvested from all cohorts of young <i>Kdm6a</i> conditional KO mice (CD45.2) and mixed with WT competitor marrow (CD45.1 x CD45.2) in a 1:1 ratio, which was then transplanted into lethally-irradiated primary recipient mice (CD45.1). …”
  18. 18
  19. 19
  20. 20